Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer ( EV-309 )
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Urothelial Cancer
Related studies linked through entity extraction aliases.
A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
International Multicentric Retrospective Study on the Use of EV+P as First-line Therapy in Patients With la/mUC
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery
- Status
- COMPLETED
- Phase
- PHASE3
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Evaluation of Clinical Outcomes, Tolerability, and Costs of Avelumab Maintenance and Pembrolizumab Second-Line Therapy in Advanced Urothelial Cancer.
- Status
- COMPLETED
- Phase
- N/A
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
DK222 Study at Hopkins
- Status
- RECRUITING
- Phase
- PHASE1
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
SLV-154 Treatment of Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- N/A
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination
- Status
- TERMINATED
- Phase
- PHASE1
A Study of ADRX-0706 in Select Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
- Status
- RECRUITING
- Phase
- N/A